Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease.

Milestones
  • 2023 → Founded
  • 2024 → Partnered, Seed + Series A
Partner
Leadership
Marc Tessier-Lavigne

Founder & CEO

Related Articles

2024: The State of Generative AI in the Enterprise